The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

aerovectrx.com

Total Raised

$700K

Investors Count

6

Deal Terms

1

AerovectRx Funding, AerovectRx Valuation & AerovectRx Revenue

3 Fundings

AerovectRx's latest funding round was a Series A for $0.7M on September 19, 2006.

AerovectRx's latest post-money valuation is from September 2006.

Sign up for a free trial to see AerovectRx's valuations in September 2006 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/19/2006

Series A

$0.7M

$99M

0

FY undefined

Incubator/Accelerator

0

FY undefined

0

Other Investors

0

FY undefined

0

Date

9/19/2006

Round

Series A

Incubator/Accelerator

Other Investors

Amount

$0.7M

Investors

Valuation

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

0

0

AerovectRx Deal Terms

1 Deal Term

AerovectRx's deal structure is available for 1 funding round, including their Series A from September 19, 2006.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

AerovectRx Investors

6 Investors

AerovectRx has 6 investors. Advanced Technology Development Center invested in AerovectRx's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/19/2006

9/19/2006

2
Incubator/Accelerator, Series A (2006)

Incubator/Accelerator

Georgia

00/00/0000

00/00/0000

Emergent Growth Fund

Subscribe to see more

Angel Investor (Group)

Florida

00/00/0000

00/00/0000

Georgia Venture Partners

Subscribe to see more

Venture Capital

Georgia

Atlanta Technology Angels

Subscribe to see more

Angel Investor (Group)

Georgia

Seed Capital Fund of CNY

Subscribe to see more

Angel Investor (Group)

New York

First funding

9/19/2006

00/00/0000

00/00/0000

Last Funding

9/19/2006

00/00/0000

00/00/0000

Investor

Emergent Growth Fund

Georgia Venture Partners

Atlanta Technology Angels

Seed Capital Fund of CNY

Rounds

2
Incubator/Accelerator, Series A (2006)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Incubator/Accelerator

Angel Investor (Group)

Venture Capital

Angel Investor (Group)

Angel Investor (Group)

Location

Georgia

Florida

Georgia

Georgia

New York

You May Also Like

D
Depotech

Depotech is developing methods for drug delivery

P
PharmaJet

PharmaJet develops, manufactures and markets vaccine and drug delivery products based on its proprietary needle free jet injection technology. PharmaJet's needle‐free injection technology delivers drugs and vaccines to intramuscular, subcutaneous and intradermal tissue depths. PharmaJet injectors use pressure to create a fine stream of liquid that penetrates the skin, delivering doses to the desired depth, while eliminating risks of needle‐stick injuries and the cost burden of "sharps" waste management. Further benefits of PharmaJet injectors include the potential for dose‐sparing of vaccines, reducing the overall cost of vaccine delivery.

M
Medlogics

Medlogics is an early stage medical device company developing a broad platform technology for drug delivery. The initial focus is product development of polymer-free stent drug delivery.

Pantec Biosolutions Logo
Pantec Biosolutions

Pantec Biosolutions is a provider of transdermal drug delivery solutions.

C
Cytogel

Cytogel, Inc., is working on the development of promising drug candidates and drug delivery technologies

R
Replenish

Replenish Inc is a Pasadena, Calif.-based developer of a drug delivery platform.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.